https://www.selleckchem.com/pr....oducts/PD-0332991.ht
0%; ≥ 2 treatment changes, 27.4%; NRTI, non-NRTI (NNRTI), and major protease inhibitor (PI) RAMs in 9.5%, 14.4%, and 3.4%, respectively. In patients with RAMs in the 2DR and 3DR groups, virologic response rates were 87.8% and 96.0%, respectively; the corresponding rates in those without RAMs were 85.7% and 81.8%. RAMs were unrelated to virologic non-response in either group. No treatment-emergent RAMs were observed. DTG + bDRV is an effective treatment option without the risk of treatment-emergent resistance for PLWH on suppressive f
Like
Comment
Share
